Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation

被引:5
作者
Campo, Gianluca [1 ,2 ]
Lunghi, Barbara [2 ,3 ]
Pavasini, Rita [1 ]
Ferraresi, Paolo [2 ,3 ]
Punzetti, Silvia [1 ]
Malagu, Michele [1 ]
Biscaglia, Simone [1 ]
Ferrari, Roberto [1 ,4 ]
Bernardi, Francesco [2 ,3 ]
机构
[1] Azienda Osped Univ S Anna, Cardiovasc Inst, Ferrara, Italy
[2] LTTA Ctr, Ferrara, Italy
[3] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy
[4] ES Hlth Sci Fdn, GVM Care & Res, Maria Cecilia Hosp, Cotignola, Italy
关键词
Factor XI; F11 rs2036914 gene polymorphism; Percutaneous coronary intervention; Myocardial infarction; Nuisance bleeding; FACTOR-IX; TRIALS;
D O I
10.1016/j.ijcard.2014.10.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:711 / 713
页数:3
相关论文
共 9 条
[1]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[2]   Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and YII [J].
Doggen, Carine J. M. ;
Rosendaal, Frits R. ;
Meijers, Joost C. M. .
BLOOD, 2006, 108 (13) :4045-4051
[3]   The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis [J].
Lunghi, Barbara ;
Cini, Michela ;
Legnani, Cristina ;
Bernardi, Francesco ;
Marchetti, Giovanna .
THROMBOSIS RESEARCH, 2012, 130 (03) :563-564
[4]   Evidence for factor IX-independent roles for factor XIa in blood coagulation [J].
Matafonov, A. ;
Cheng, Q. ;
Geng, Y. ;
Verhamme, I. M. ;
Umunakwe, O. ;
Tucker, E. I. ;
Sun, M. -F. ;
Serebrov, V. ;
Gruber, A. ;
Gailani, D. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (12) :2118-2127
[5]   Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium [J].
Mehran, Roxana ;
Rao, Sunil V. ;
Bhatt, Deepak L. ;
Gibson, C. Michael ;
Caixeta, Adriano ;
Eikelboom, John ;
Kaul, Sanjay ;
Wiviott, Stephen D. ;
Menon, Venu ;
Nikolsky, Eugenia ;
Serebruany, Victor ;
Valgimigli, Marco ;
Vranckx, Pascal ;
Taggart, David ;
Sabik, Joseph F. ;
Cutlip, Donald E. ;
Krucoff, Mitchell W. ;
Ohman, E. Magnus ;
Steg, Philippe Gabriel ;
White, Harvey .
CIRCULATION, 2011, 123 (23) :2736-U144
[6]   Activation of clotting factors XI and IX in patients with acute myocardial infarction [J].
Minnema, MC ;
Peters, RJG ;
de Winter, R ;
Lubbers, YPT ;
Barzegar, S ;
Bauer, KA ;
Rosenberg, RD ;
Hack, CE ;
ten Cate, H .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (11) :2489-2493
[7]   Inherited factor XI deficiency confers no protection against acute myocardial infarction [J].
Salomon, O ;
Steinberg, DM ;
Dardik, R ;
Rosenberg, N ;
Zivelin, A ;
Tamarin, I ;
Ravid, B ;
Berliner, S ;
Seligsohn, U .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (04) :658-661
[8]  
Thygesen K, 2012, CIRCULATION, V126, P2020, DOI [10.1093/eurheartj/ehs184, 10.1161/CIR.0b013e31826e1058, 10.1016/j.gheart.2012.08.001, 10.1016/j.jacc.2012.08.001]
[9]   Tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R).: Rationale for the study and protocol design [J].
Valgimigli, Marco ;
Campo, Gianluca ;
de Cesare, Nicoletta ;
Vranckx, Pascal ;
Hamon, Martial ;
Angiolillo, Dominick J. ;
Sabate, Manel ;
Ferrari, Fabrizio ;
Furgieri, Alessandro ;
Tumscitz, Carlo ;
Repetto, Alessandra ;
Colangelo, Salvatore ;
Meliga, Emanuele ;
Kubbajeh, Moh'd ;
Parrinello, Giovanni ;
Percoco, Gianfranco ;
Ferrari, Roberto .
CARDIOVASCULAR DRUGS AND THERAPY, 2008, 22 (04) :313-320